Zhang Xiaofan Neo
SEC insider (Form 3/4/5 filer). CIK 0002121304. Chief Investment Officer at NovaBridge Biosciences (NBP). 1 Form 3 filing on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024. Located in ROCKVILLE, MD.
Companies Zhang Xiaofan Neo has filed insider reports for
- NovaBridge Biosciences (NBP): Officer, Chief Investment Officer
Zhang Xiaofan Neo
CIK: 0002121304
Transaction Breakdown
Open Market Buys (P)0
High conviction signal
Open Market Sales (S)0
Position reduction
Option Exercises (M)0
Derivative conversions
Awards (A)0
Compensation grants
Other (G, F, J, C, D, …)0
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
NBP
NovaBridge Biosciences
Officer
Discretionary Trading P&L
Holdings
Transaction History (0 total)
1 Form 3 filing on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024.
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| 1 Form 3 filing on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024. | ||||||
0-0 of 0 transactions